The noradrenaline transporter as site of action for the anti-Parkinson drug amantadine

Heteromeric NMDA Receptors: Molecular and Functional Distinction of Subtypes

Hannah Monyer, Rolf Sprengel, Ralf Schoepfer et al. · Science · 1992 · 2.5K citations

Life Sciences, Neurobiology, Neuroscience +15

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

Richard B. Rothman, Michael H. Baumann, Christina M. Dersch et al. · Synapse · 2000 · 931 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Amantadine in the Treatment of Parkinson's Disease

Robert S. Schwab · JAMA · 1969 · 631 citations

Medicine, Pharmacology, Pharmacotherapy +10

Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity

HS Chen, JW Pellegrini, SK Aggarwal et al. · Journal of Neuroscience · 1992 · 631 citations · Full text

Medicine, Neuroscience, Pharmacology +14

Amantadine as treatment for dyskinesias and motor fluctuations in Parkinson's disease

Leonard Verhagen Metman, Paolo Del Dotto, Pepijn van den Munckhof et al. · Neurology · 1998 · 516 citations

Medicine, Pharmacology, Pharmacotherapy +17